World Summit on Liver Cirrhosis and Hepatitis November 07-08, 2018 Holiday Inn Atrium, Singapore

Conferenceseries LLC ltd welcomes you to attend World Summit on Liver Cirrhosis and Hepatitis to speak on a theme “Research and development in Liver Cirrhosis and Hepatitis” during November 07-08 , 2018 Singapore which is going to cover all aspects on scientific and technical advances in the field of medical science, environmental science and pharmaceutical science.

Following are the sessions and tracks which are going to discuss at Liver Cirrhosis 2018:

Track 1: Liver Function

The liver is the body’s largest internal organ that sits on the right hand side of the belly. It is an essential organ that has many functions in the body, including making proteins and blood clotting factors, manufacturing triglycerides and cholesterol, glycogen synthesis and bile production. The liver filters the blood coming from the digestive tract and also detoxifies the chemicals and metabolizes the vitamins, proteins, fats, carbohydrates and drugs. The liver secrets the bile that ends up back in the intestine.

·         Blood Detoxification and Purification

·         Bile Production and Excretion

·         Metabolism of Fats, Proteins and Carbohydrates

·         Synthesis of Plasma Proteins

Related Conferences:  Liver Conferences | Liver Health Congress | Liver Meetings | Liver Disease Conferences | Gastroenterology Conferences

World Liver Conference 2018  May 25-26, 2018, New York, USA; 3^rd International Conference on Pancreatic Cancer and Liver Diseases June 18-19, 2018 Rome, Italy; 6^th World Congress on Hepatitis & Liver Diseases June 18-20, 2018 Dublin, Ireland; 14^th World Congress on Gastroenterology and Hepatology  June 25-27, 2018 Stockholm, Sweden; Euro Global Congress on HCV June 28-30, 2018 Amsterdam, Netherlands; International Conference on Gastroenterology & Digestive Disorders May 14-16, 2018 Melbourne, Australia; Canadian Liver Meeting February 09-11, 2018 Toronto; Annual Conference April 27-28, 2018 Houston, Texas; 12^th Annual Conference of the International Liver Cancer Association September 14-16, 2018 London, United Kingdom;  The International Liver Congress  April 11-15 , 2018 Paris.

American Association for the Study of Liver Diseases – AASLD, American Liver Foundation, Chronic Liver Disease Foundation, Gay and Lesbian Medical Association, Hepatitis Foundation International, Hepatitis B Foundation - IAC, Immunization Action Coalition – NHCAC.

Track 2: Liver Immunology

The human liver is usually perceived as a non-immunological organ engaged primarily in metabolic, nutrient storage and detoxification activities. The healthy liver is also a site of complex immunological activity mediated by a diverse immune cell repertoire as well as non-hematopoietic cell populations. In the non-diseased liver, metabolic and tissue remodeling functions require elements of inflammation. In this complex microenvironment, the hepatic immune system tolerates harmless molecules while at the same time remaining alert to possible infectious agents, malignant cells or tissue damage.

In the healthy liver, constantly changing metabolic and tissue remodeling activity, combined with regular exposure to microbial products, results in persistent, regulated inflammation. These inflammatory processes act in a tightly controlled fashion and are stimulated to additional activity only when the liver is required to rid itself of hepatotropic pathogens, malignant cells or toxic products of metabolic activity. Failure to clear such dangerous stimuli and resolve inflammation, leads to chronic infection, autoimmunity or tumor growth. This is inevitably associated with chronic pathological inflammation and disrupted tissue homeostasis, which can progress to fibrosis, cirrhosis and liver failure.

·         Liver Immune Tolerance

·         Liver as an Immunological Organ

·         Hepatic Innate Immunity

·         Liver Sinusoidal Endothelial Cells

Related Conferences:  Immunology Conferences | Liver Tumor Conferences | Hepatitis Conferences |liver symposiums | Liver Tissue Congress

 15^th International Conference on Digestive Disorders and Gastroenterology July 11-12, 2018 Sydney, Australia; 15^th International Conference on Digestive Disorders and Gastroenterology July 11-12, 2018 Sydney, Australia; 16^th International Conference on Gastroenterology and Digestive Disorders August 06-07, 2018 Abu Dhabi, UAE; 8^th International Conference and Exhibition on Cell & Gene Therapy August 21-22, 2018 Paris, France; 13^th Euro-Global Gastroenterology Conference August 20-21, 2018 Rome, Italy; The Liver Meeting November 09-13,2018 San Francisco; International Liver Transplant Society International Congress  (ILTS 2018)  May 23-26, 2018  Lisbon; Gut-liver Axis 2018  June 7-9, 2018 Leuven; Singapore Hepatology Conference  June 8-9, 2018 Singapore; 16^th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD Global Hepatitis Summit)  June 14 – 17, 2018 Toronto, Canada.

National Hepatitis C Advocacy Council, National Institute of Health, New York City Department of Health and Mental Hygiene, Veterans Affairs - Center for Excellence in Hepatitis C Research and Education, British Liver Trust, Canadian Liver Foundation – CLF,  Canadian Liver Foundation  - Canada (CA).

Track 3: Clinical and Molecular Hepatology

Medical doctors and basic scientists working in the field of hepatology and to contribute to the improvement of public health through a multidisciplinary approach by sharing advanced basic and clinical research results for various diseases of the liver and biliary tract. The journal present up-to-date coverage of basic and clinical researches on molecular and cell biology, pathophysiology, epidemiology, diagnosis, and treatment of the various diseases of the liver and biliary tract, with special attention to more common liver diseases of the Asian-Pacific region such as B viral hepatitis and hepatocellular carcinoma. Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world. Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. 

·         Drug-Induced Liver Injury

·         Liver Fibrosis

·         Gastro esophageal Varices due to Liver Cirrhosis

·         Jaundice

Related Conferences:  Hepatology Conferences | Clinical Hepatology Conferences | Molecular Hepatology Conferences | Global Hepatology Conferences | Global Hepatitis Summit

14^th International Conference on Clinical Gastroenterology and Hepatology August 29-30,2018 Toronto, Ontario, Canada; 17^th International Conference on Gastroenterology and Hepatology September 03-04, 2018 Dubai, UAE; 18^th World Gastroenterologists Summit September 07-08, 2018 Auckland, New Zealand; 3^rd International Conference on Hepatobiliary & Pancreatic Disorders  September 17-18, 2018 Philadelphia, Pennsylvania, USA; International Metabolic Diseases and Liver Cancer Conference September 17-18, 2018         Dubai, UAE; Liver Transplant Course 2018 February 01-02,2018 Innsbruck; 13^th Congress of the European Crohn's and Colitis Organization February 14 -17, 2018 Vienna, Austria; The Liver Week 2018 June 14 – 16, 2018 Grand Hyatt Incheon, Korea; HBP Surgery Week 2018 March 30-31,2018 Busan, Korea; ILCA School of Liver Cancer 2018  May 18-19, 2018 Bologna, Italy.

American Society of Clinical Oncology  - ASCO, U.S. Department of Health and Human Services, Macmillan Cancer support, Cancer Research UK, Love your liver  - Australia, National Foundation for Infectious Diseases – NFID,  American Liver Society  - ALS.

Track 4: Liver Metastasis

A liver metastasis is a cancerous tumor that has spread to the liver from a cancer that started in another place in the body. It’s also called secondary liver cancer. Primary liver cancer originates in the liver and most commonly affects individuals who have risk factors such as hepatitis or cirrhosis. Cancer in the liver is secondary, or metastatic. There may be no symptoms in the early stages of liver metastasis. In later stages, cancer can cause the liver to swell or obstruct the normal flow of blood and bile. When this happens, loss of appetite, weight loss, dark-colored urine, abdominal swelling or bloating, jaundice, a yellowing of the skin or the whites of the eyes, pain in the right shoulder, pain in the upper right abdomen, nausea, vomiting, confusion, sweats and fever, enlarged liver.

·         Symptoms of Liver Metastasis

·         Liver Metastasis-Diagnosis

·         Treatments

·         Supportive Therapies

Related Conferences: Liver Cancer Meetings | Liver metastasis Conferences | Liver therapy Conferences | Cancer therapy Conferences |Hepatitis C Conferences

6^th International Conference on Hepatology September 21-22, 2018 Osaka, Japan; 3^rd World Liver Congress October 15-16, 2018 Abu Dhabi, UAE;  4^th World Congress on Digestive & Metabolic Diseases October 29-30, 2018 San Francisco, California, USA; 3^rd International conference on Digestive and Metabolic Diseases October 22-23, 2018 Berlin , Germany; 13^th International Conference on Clinical Gastroenterology & Hepatology October 17-18, 2018 Rome, Italy; 6th Annual Liver Course Birmingham Liver Course May 24-25, 2018 University of Birmingham, Edgbaston campus; The ESMO World Congress on Gastrointestinal Cancer 2018 June 20-23, 2018 Barcelona, Spain; National Liver Conference September 21,2018 Austin, Texas; The 9^th Asia-Pacific Primary Liver Cancer Expert Meeting  July 06-08, 2018 Grand Hyatt Seoul, Korea; Liver Congress 2018 October 15-16 , 2018 Abu Dhabi, United Arab Emirates.

British Association for the Study of the Liver – BASL,  British Liver Trust, National charity for adult liver disease - United Kingdom, Canadian Association for the Study of the Liver  - CASL, Childhood Liver Tumor Study Group – SIOPEL, Children's Liver Alliance  - CLA, Children's Liver Disease Foundation – CLDF, Euro liver Foundation.

Track 5: Liver Cirrhosis

Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function which include Fluid accumulation in your abdomen (ascites), Confusion, drowsiness and slurred speech (hepatic encephalopathy), Testicular atrophy in men, Breast enlargement in men. Cirrhosis can also cause portal hypertension, Enlargement of the spleen (splenomegaly).

·         Prevention of Liver Cirrhosis

·         Causes of Liver Cirrhosis

·         Liver Cirrhosis- Symptoms

·         Treatments

Related Conferences:  Liver Cirrhosis Conferences | Cirrhosis Conferences | Cirrhosis Meetings| Liver Cirrhosis Meetings | Liver cirrhosis Congress  

15^th World Congress on Gastroenterology & Therapeutics November 08-09, 2018 Auckland, New Zealand; "World Liver Conference 2018" May 25-26, 2018 New York, USA; 3^rd International Conference on Pancreatic Cancer and Liver Diseases June 18-19, 2018 Rome, Italy; 6^th World Congress on Hepatitis & Liver Diseases June 18-20, 2018 Dublin, Ireland; 14^th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden; Hepatology Congress 2018 June 09-10, 2018 Vienna, Austria; International Conference on Gastroenterology & Digestive Disorders May 14-16, 2018 Melbourne, Australia; Canadian Liver Meeting  February 09-11, 2018 Toronto; 2018 Annual Conference April 27-28, 2018 Houston, Texas; 12^th Annual Conference of the International Liver Cancer Association September 14-16, 2018 London, United Kingdom.

European Association for the Study of the Liver – EASL, Hong Kong Liver Foundation, International Hepato Pancreato Biliary Association – IHPBA,  International Liver Transplantation Society – ILTS, Korea Liver Foundation - South Korea (KLF), Latino Organization for Liver Awareness – LOLA, Primary Biliary Cirrhosis Foundation - PBC Foundation.

Track 6: Hepatitis and its Types

Hepatitis refers to an inflammatory condition of the liver. It’s commonly caused by a viral infection, but there are other possible causes of hepatitis. These include autoimmune hepatitis and hepatitis that occurs as a secondary result of medications, drugs, toxins, and alcohol. Autoimmune hepatitis is a disease that occurs when your body makes antibodies against your liver tissue. Viral infections of the liver that are classified as hepatitis include hepatitis A, B, C, D, and E. A liver biopsy is an invasive procedure that involves your doctor taking a sample of tissue from your liver. This test allows your doctor to determine how infection or inflammation has affected your liver. Corticosteroids, like prednisone or budesonide, are extremely important in the early treatment of autoimmune hepatitis.

·         Auto-immune Hepatitis

·         Viral Hepatitis

·         Alcoholic hepatitis

Related Conferences:  Global Hepatitis Conferences | Liver and Hepatitis congress | Fibrosis and Cirrhosis Conferences | Hepatitis C Congress | World Liver Conferences

Euro Global Congress on HCV June 28-30, 2018 Amsterdam, Netherlands; 15^th International Conference on Digestive Disorders and Gastroenterology July 11-12, 2018 Sydney, Australia; 16^th International Conference on Gastroenterology and Digestive Disorders August 06-07, 2018 Abu Dhabi, UAE; 8^th  International Conference and Exhibition on Cell & Gene Therapy August 21-22, 2018 Paris, France; 3^rd International Conference on Hepatobiliary & Pancreatic Disorders September 17-18, 2018 Philadelphia, Pennsylvania, USA ; The International Liver Congress April  11-15 , 2018 Paris; The Liver Meeting November  09-13,2018 San Francisco; International Liver Transplant Society International Congress  (ILTS 2018) May 23-26, 2018 Lisbon; Gut-liver Axis 2018  June 7-9, 2018 Leuven; Singapore Hepatology Conference  June 8-9, 2018 Singapore.

Primary Biliary Cirrhosis Organization – PBCers, Research Center for Alcoholic Liver and Pancreatic Diseases, Swiss Association for the Study of the Liver - Switzerland (CH) – SASL, Hepatitis Education, Awareness, and Liver Support  of North Georgia – HEALS, European Liver Patients' Association, South Asian Association for Study of the Liver – SAASL, Children's Liver Association For Support Services - C.L.A.S.S.

Track 7: Causes of Hepatitis

Hepatitis is an inflammation of the liver characterized by diffuse or patchy necrosis. Autoimmune hepatitis (AIH) is one exception. This type of liver disease occurs when your immune system attacks your liver cells. AIH is a chronic condition that can result in cirrhosis (scarring) of the liver. certain risk factors have been identified, including mainly a family history of AIH. Autoimmune hepatitis likely results from a combination of autoimmunity, environmental triggers, and a genetic predisposition. It occurs more frequently in females. Treatment typically includes corticosteroids and medications that suppress the immune system. In severe cases, a liver transplant may be needed. Ischemic hepatitis differs from other types of hepatitis. Which can have many causes, most commonly a virus (as in hepatitis A or B). However, in ischemic hepatitis, the liver is not inflamed. Rather, liver cell death (necrosis) occurs. The term hepatitis is used because technically, it refers to any disorder in which liver enzymes called aminotransferases leak from damaged liver cells into the blood.

·         Autoimmune Hepatitis

·         Genetic disorders leading to Hepatitis

·         Infectious

·         Ischemic Hepatitis

Related Conferences:  Hepatitis B Conferences | Genetic Hepatitis Congress | Viral Hepatitis conference |World Liver Congress | Liver Regeneration Summits

13^th Euro-Global Gastroenterology Conference  August 20-21, 2018 Rome, Italy; 14^th International Conference on Clinical Gastroenterology and Hepatology August 29-30, 2018 Toronto, Ontario, Canada; 17^th International Conference on Gastroenterology and Hepatology September 03-04, 2018 Dubai, UAE; 18^th World Gastroenterologists Summit   September 07-08, 2018   Auckland, New Zealand; 3rd International Conference on Hepatobiliary & Pancreatic Disorders September 17-18, 2018 Philadelphia, Pennsylvania, USA; 16^th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD Global Hepatitis Summit) June 14 –17, 2018 Toronto, Canada; Liver Transplant Course 2018 February 01-02, 2018 Innsbruck; 13^th Congress of the European Crohn's and Colitis Organization February 14 -17, 2018 Vienna, Austria; The Liver Week 2018 June 14 – 16, 2018 Grand Hyatt Incheon, Korea; HBP Surgery Week 2018 March 30-31,2018 Busan, Korea; Global Hepatitis Summit 2018 June 14-17, 2018 Toronto, Canada

Blue Faery: the Adrienne Wilson Liver Cancer Association, Hepatology Society of the Philippines, Philippine Society of Gastroenterology – PSG, National Liver Foundation of Bangladesh, The Alpha-1 Foundation, Florida, The American Transplant Foundation, Canadian Association of Hepatology Nurses -  CAHN.

Track 8: Prevention and Treatment for Hepatitis

To diagnose hepatitis, first your doctor will take your history to determine any risk factors you may have for infectious or noninfectious hepatitis. Liver function tests use blood samples to determine how efficiently your liver works.

 High liver enzyme levels may indicate that your liver is stressed, damaged, or not functioning properly. An abdominal ultrasound uses ultrasound waves to create an image of the organs within your abdomen. It can reveal Liver tumors, Liver failure, Abnormalities of gall bladder. Treatment options are determined by which type of hepatitis you have and whether the infection is acute or chronic.

·         Immunization

·         Vaccination

·         Anti-viral Drug Therapies

·         Liver Transplant

Related Conferences:  Hepatitis Meetings | Liver Transplantation Congress | Gastrointestinal meetings organ Transplantations | Liver Cancer Congress

International Metabolic Diseases and Liver Cancer Conference  September 17-18, 2018 Dubai, UAE; 6^th International Conference on Hepatology September 21-22, 2018 Osaka, Japan;3^rd World Liver Congress October 15-16, 2018 Abu Dhabi, UAE; 4^th World Congress on Digestive & Metabolic Diseases October 29-30, 2018 San Francisco, California, USA; 3^rd International conference on Digestive and Metabolic Diseases October 22-23, 2018 Berlin , Germany; ILCA School of Liver Cancer 2018 May 18-19, 2018 Bologna, Italy; 6^th Annual Liver Course Birmingham Liver Course May 24-25, 2018 University of Birmingham, Edgbaston campus; The ESMO World Congress on Gastrointestinal Cancer 2018 June 20-23, 2018 Barcelona, Spain;  National Liver Conference September 21,2018 Austin, Texas; The 9th Asia-Pacific Primary Liver Cancer Expert Meeting July 06-08, 2018 Grand Hyatt Seoul, Korea.

The Canadian Network on Hepatitis C – CANHEPC, Texas Society for Gastroenterology and Endoscopy, International Association for the Study of the Liver – IASL, Wilson Disease Association, Fatty Liver Foundation, The Korean Liver Transplantation Society, The Korean Liver Cancer Association.

Track 9: Antiviral Drugs for Cirrhosis and Hepatitis

Viruses are the intracellular parasites that depend on synthetic processes of host cells. They cannot be grown on ordinary medium. Special microscopes are needed to visualize their structure, which consists of Genome (genetic material consisting of DNA or RNA component but never both), Surrounding capsid –proteinaceous in structure, Envelope –protein bilayer. Hepatitis B virus (HBV) is an important cause of end-stage liver disease and hepatocellular carcinoma(HCC). The decision to treat is based on the activity of liver disease and HBV replication status, and the likelihood of a long-term benefit. Approved therapies include standard and pegylated interferon-alfa and nucleoside analogues: lamivudine, adefovir and entecavir. Even with successful therapy, patients remain at risk for reactivation of viral replication and require lifelong monitoring.

HBV in HBsAg-positive patients treated with allogeneic hematopoietic cell transplantation. Highly active antiretroviral therapy is initiated for decreasing mortality relating to HIV. Influenza can be type A, B or C depending upon type. Influenza A and B are more common.

·         Anti-herpes virus agents

·         Anti-retroviral agents

·         Anti influenza agents

·         Antiviral Regimens

Related Conferences:  Cell Transplantation Congress | Obesity Meetings | Liver Donor Meetings | Viral Diseases Conferences

15^th World Congress on Gastroenterology & Therapeutics November 08-09, 2018 Auckland, New Zealand; "World Liver Conference 2018" May 25-26, 2018 New York City, New York, USA; 3^rd International Conference on Pancreatic Cancer and Liver Diseases June 18-19, 2018 Rome, Italy; 6^th World Congress on Hepatitis & Liver Diseases June 18-20, 2018 Dublin, Ireland; 14^th World Congress on Gastroenterology and Hepatology  June 25-27, 2018 Stockholm, Sweden; Liver Congress 2018 October 15-16, 2018 Abu Dhabi, United Arab Emirates; Hepatology Congress 2018  June 09-10, 2018 Vienna, Austria; The Liver Meeting November 09-13, 2018  San Francisco; International Liver Transplant Society International Congress (ILTS 2018)  May 23-26, 2018  Lisbon ; Gut-liver Axis 2018  June 7-9, 2018 Leuven.

The Korean Association of Hepato Biliary Pancreatic Surgery, The Korean Association for the Study of the Liver, World Hepatitis Alliance – WHA, Australasian Hepatology Association – AHA, American Gastroenterological Association – AGA, Mexican Association of Hepatology (Publons), Indian National Association for Study of the Liver – INASL.

Track 10: Hepatobiliary  diseases

Hepatobiliary diseases are diseases that affect the biliary tract or the liver. Cholangiocarcinoma is usually a bile duct that presents a malignant tumor. Treating the disease requires removal and/or resection. Biliary strictures (both malignant and benign) – occur when the bile ducts become inflamed or injured. The ducts narrow and form a stricture. They are often caused by injury or cancer. Bile duct stones – are stones that occur within the bile duct, similar to a gallstone. They often start developing in the gallbladder and make their way into the bile duct. The hepatobiliary system is made up of the liver, gall bladder and bile ducts. Conditions or diseases that cause harm to these areas, which can be life threatening, are referred to as hepatobiliary diseases.

 Caroli disease and Caroli syndrome are rare congenital disorders of the intrahepatic bile ducts. They are both characterized by dilatation of the intrahepatic biliary tree. The term Caroli disease is applied if the disease is limited to ectasia or segmental dilatation of the larger intrahepatic ducts. Biliary atresia is a rare disease of the liver and bile ducts that occurs in infants. Neonatal hemochromatosis is a syndrome in which severe liver disease of fetal or perinatal onset is associated with deposition of stainable iron in extrahepatic sites. ... Survival rates in babies who undergo liver transplantation are reportedly 50%.

·         Cholangiocarcinoma (biliary tree cancer)

·         Primary Neonatal Hemochromatosis

·         Acute liver failure

·         Biliary atresia

·         Pediatric Caroli disease

Related Conferences: Pediatric Meetings | Diabetes Conferences | Bile duct congress |Hepatobiliary Conferences | World liver Summits

Euro Global Congress on HCV June 28-30, 2018 Amsterdam, Netherlands; 15th International Conference on Digestive Disorders and Gastroenterology July 11-12, 2018 Sydney, Australia;16^th International Conference on Gastroenterology and Digestive Disorders August 06-07, 2018 Abu Dhabi, UAE; 8^th International Conference and Exhibition on Cell & Gene Therapy August 21-22, 2018 Paris, France; 13^th  Euro-Global Gastroenterology Conference August 20-21, 2018 Rome, Italy; 14^th International Conference on Clinical Gastroenterology and Hepatology  August 29-30, 2018 Toronto, Ontario, Canada Singapore Hepatology Conference  June 08 - 09, 2018 Singapore; 16^th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD Global Hepatitis Summit) June 14 – 17, 2018  Toronto, Canada; Liver Transplant Course 2018  February 01-02,2018  Innsbruck ; 13^th Congress of the European Crohn's and Colitis Organization February 14 -17, 2018 Vienna, Austria; The Liver Week 2018      June 14–16, 2018 Grand Hyatt Incheon, Korea.

North American Society for Pediatric Gastroenterology, Hepatology and Nutrition – NASPGHAN,  Latin American Society for Pediatric Gastroenterology, Hepatology, and Nutrition – LASPGHAN, European Society for Pediatric Gastroenterology, Hepatology and Nutrion – ESPGHAN, Asian Pan Pacific Society for pediatric Gastroenterology, Hepatology and Nutrition – AAPSGHAN, Commonwealth Association Pediatric Gastroenterology and Nutrition – CAPGAN, The Gastroenterology and Hepatology Association of sub-Saharan Africa – GHASSA, Massachusetts Gastroenterology Association.

Track 11: Liver Steatosis

It is normal for the liver to contain some fat and by itself, this causes no symptoms. In some patients, the excess fat can cause inflammation called steatohepatitis. Steatohepatitis can lead to cirrhosis (fibrosis, scarring and hardening of the liver). There is also an association with liver cancer (hepatocellular carcinoma). Fatty liver can be classified as alcohol and nonalcohol related. Alcohol is a direct toxin to the liver and can cause inflammation. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic related steatohepatitis (NASH).

Obesity is a major health problem worldwide. Obesity also increases the risk of developing several chronic diseases such as type II diabetes, insulin resistance, coronary heart disease (responsible for heart attacks), cerebrovascular disease (responsible for strokes), high blood pressure, gout, gallstones, colon cancer, sleep apnea, and a form of liver disease called nonalcoholic fatty liver disease (NAFLD). Acute fatty liver of pregnancy (AFLP) is a rare, potentially fatal complication that occurs in the third trimester or early postpartum period. Although the exact pathogenesis is unknown, this disease has been linked to an abnormality in fetal fatty acid metabolism. Early diagnosis of AFLP sometimes can be difficult because it shares features with other common conditions such as pre-eclampsia, viral hepatitis and cholestasis of pregnancy.

·         Nonalcoholic Steatohepatitis

·         Alcoholic steatohepatitis

·         Obesity and Liver Steatosis

·         Acute fatty liver of pregnancy

Related Conferences:  Obesity congress | Fatty Liver Meeting | Obesity symposium | International Liver Conferences | Global Hepatitis Summit

17^th International Conference on Gastroenterology and Hepatology September  03-04, 2018 Dubai, UAE; 18^th World Gastroenterologists Summit September 07-08, 2018 Auckland, New Zealand; 3^rd International Conference on Hepatobiliary & Pancreatic Disorders September 17-18, 2018 Philadelphia, Pennsylvania, USA; International Metabolic Diseases and Liver Cancer Conference September 17-18, 2018 Dubai, UAE; 6^th International Conference on Hepatology September 21-22, 2018 Osaka, Japan; HBP Surgery Week 2018 March 30-31,2018 Busan, Korea; ILCA School of Liver Cancer 2018 May 18-19, 2018 Bologna, Italy; 6^th Annual Liver Course Birmingham Liver Course May 24-25, 2018 University of Birmingham, Edgbaston campus; The ESMO World Congress on Gastrointestinal Cancer 2018 June 20-23, 2018 Barcelona, Spain; National Liver Conference September 21,2018 Austin, Texas; The 9^th Asia-Pacific Primary Liver Cancer Expert Meeting July 06-08, 2018 Grand Hyatt Seoul, Korea.

Iranian Association of Gastroenterology and Hepatology and Shiraz University of Medical Sciences, British Society of Pediatric Gastroenterology, Hepatology and Nutrition – BSPGHAN, Saudi Gastroenterology Association, Emirates Gastroenterology & Hepatology Society, The Israeli Society of Gastroenterology and Liver Disease, The Japan Society of Hepatology, International Liver Cancer Association.

Track 12: Liver Health

It's not something you probably think much about, but your liver is a key player in your body's digestive system. Everything you eat or drink, including medicine, passes through it. You need to treat it right so it can stay healthy and do its job. Eat a healthy diet and get regular exercise. Your liver will thank you. You'll keep your weight under control, which helps prevent nonalcoholic fatty liver disease (NAFLD), a condition that leads to cirrhosis. Watch out for certain medicines. Some cholesterol drugs can occasionally have a side effect that causes liver problems. Alcoholic beverages can create many health problems. They can damage or destroy liver cells and scar your liver.

·         Hygiene

·         Vaccination

·         Alcohol use

·         Diet and Exercise

Related Conferences:  Liver congress| Liver injury Meetings | Gastroenterology Summits | World Gastroenterology Meetings | Global Gastro Hep Summits

6^th International Conference on Hepatology September 21-22, 2018 Osaka, Japan; 3^rd World Liver Congress October 15-16, 2018 Abu Dhabi, UAE;  4^th World Congress on Digestive & Metabolic Diseases October 29-30, 2018 San Francisco, California, USA; 3^rd International conference on Digestive and Metabolic Diseases October 22-23, 2018 Berlin , Germany; 13^th International Conference on Clinical Gastroenterology & Hepatology  October 17-18, 2018 Rome, Italy; 6^th Annual Liver Course Birmingham Liver Course May 24-25, 2018 University of Birmingham, Edgbaston campus; The ESMO World Congress on Gastrointestinal Cancer 2018 June 20-23, 2018 Barcelona, Spain; National Liver Conference September 21, 2018 Austin, Texas; The 9^th Asia-Pacific Primary Liver Cancer Expert Meeting  July 06-08, 2018 Grand Hyatt Seoul, Korea; Liver Congress 2018 October 15-16 , 2018 Abu Dhabi, United Arab Emirates.

The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases in Alexandria – ESHGID, Indonesian Association for the Study of the Liver, South Asian Association for the Study of the Liver, United Network for Organ Sharing – UNOS, Tasmanian Council on AIDS, Hepatitis and Related Diseases, National Foundation for Infectious Diseases – NFID.